| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Klassen Preston | President & Head of R & D, Director | C/O REGULUS THERAPEUTICS INC., 4224 CAMPUS POINT CT., #210, SAN DIEGO | Christopher Aker, Attorney in Fact | 04 Jun 2025 | 0001493056 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGLS | Common Stock | Purchase | $95,852 | +12,000 | +33% | $7.99 | 48,055 | 03 Jun 2025 | Direct |